TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Pharmaq Fishteq AS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
35,763
|
34,530
|
36,741 |
Financial expenses |
1,137
|
916
|
1,116 |
Earnings before taxes |
5,794
|
-19,108
|
-2,603 |
Total assets |
24,393
|
48,259
|
53,318 |
Current assets |
14,778
|
35,848
|
21,714 |
Current liabilities |
12,210
|
39,852
|
43,332 |
Equity capital |
12,182
|
8,211
|
9,549 |
- share capital |
56
|
60
|
63 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
49.9%
|
17.0%
|
17.9% |
Turnover per employee | |||
Profit as a percentage of turnover |
16.2%
|
-55.3%
|
-7.1% |
Return on assets (ROA) |
28.4%
|
-37.7%
|
-2.8% |
Current ratio |
121.0%
|
90.0%
|
50.1% |
Return on equity (ROE) |
47.6%
|
-232.7%
|
-27.3% |
Change turnover |
3,355
|
-281
|
4,019 |
Change turnover % |
10%
|
-1%
|
12% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.